Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

9
SunTrust (STI) Q2 Earnings Beat Estimates, Revenues Improve

2018-07-20 zacks
SunTrust Banks' (STI - Free Report) second-quarter 2018 earnings of $1.49 per share outpaced the Zacks Consensus Estimate of $1.30. Also, the figure compared favorably with the prior-year quarter’s earnings of $1.03. Results were primarily driven by rise in revenues as well as lower provisions. Also, an improvement in overall asset quality was a tailwind. However, higher expenses hurt results to some extent.
STI.WS.B STI.WS.A C CMA PNC.PRP PNC.PRQ PNCFO PNC.WS STI PNC STI-A PNUCL STI.PRE

11
BB&T (BBT) Posts In-Line Earnings in Q2, Provisions Stable

2018-07-19 zacks
BB&T Corporation’s (BBT - Free Report) second-quarter 2018 adjusted earnings of $1.01 was in-line with the Zacks Consensus Estimate. Moreover, the figure recorded 29.5% surge from the year-ago quarter. Results reflected slight rise in revenues and lower operating expenses. Also, the balance sheet position remained strong during the quarter under review. Further, stable provisions supported results to some extent.
BBT PNC.WS C CMA PNC.PRP PNC PNC.PRQ PNUCL PNCFO

28
What Will Happen When The Market Has A Down Year?

2018-07-19 seekingalpha
Global equity markets continued to advance. Last week's newsletter noted the importance of closing the week above the all-important 2750 level in the EMINI SP500 Sept contract. We knew this level was huge, considering the close below on June 29th sent the contract below our 7-week moving average and was on the cusp of losing further ground. But all tariff worries aside, all geopolitical NATO posturing aside, the equity markets continued their advance on the tailwinds of massive continued corporate buybacks.
WFCNP WFC.PRL WFC.PRJ WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN AVGO WFC.PRY WFC.PRX WFC.PRW WFC.PRV WFC WFC.WS C AAL PNC.PRP PNC.PRQ PNCFO CAIAF CA PNC.WS JPM PNC PNUCL BRCM PZZA

64
Bank of America Strengthens – and BAC Stock Doesn’t

2018-07-18 investorplace
U.S. bank stocks like Bank of America (NYSE:BAC) haven’t had a particularly spectacular 2018. BAC stock, for instance, is up less than 2% so far this year. It’s pulled back about 9% from March highs — and hit a seven-month low in July before rallying.
WFC WFCNP WFC.WS C WFC.PRL WFC.PRJ BAC WFC.PRT WFC.PRR WFC.PRQ WFC.PRP JPM WFC.PRO WFC.PRN PNC WFC.PRY WFC.PRX WFC.PRW WFC.PRV

9
M&T Bank (MTB) Q2 Earnings and Revenues Beat, Expenses Up

2018-07-18 zacks
M&T Bank Corporation (MTB - Free Report) reported net operating earnings of $3.29 per share in second-quarter 2018, surpassing the Zacks Consensus Estimate of $3.17. Also, the bottom line improved 38% year over year.
C FRC PNC.PRP PNC.PRQ PNCFO FRC.PRA PNC.WS PNC PNUCL FRC.PRI FRC.PRH FRC.PRG FRC.PRF FRC.PRE FRC.PRD FRC.PRC FRC.PRB

66
Slow Progress Not Getting The Job Done For Citigroup Shares

2018-07-18 seekingalpha
Citi's second-quarter earnings were a little better than expected, with decent loan growth, sound credit, and okay net interest income growth.
WFCNP WFC.PRL WFC.PRJ BAC USB WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN WFC.PRY WFC.PRX WFC.PRW WFC.PRV WFC WFC.WS C PNC.PRP PNC.PRQ PNCFO COF PNC.WS JPM PNC PNUCL

23
5 Strong Earnings Stocks to Buy Post-Netflix Plunge | InvestorPlace

2018-07-17 investorplace
Netflix, Inc. (NASDAQ:NFLX) may be plunging 14% right now. But don’t let that faze you. There is a reason why the Street has always been cautious about investing in Netflix. Even now I can see that top analysts only have a cautiously optimistic Buy rating on NFLX. And post-plunge they are still only modelling for 4% upside potential from current levels. Netflix is still expensive full stop.
WFCNP FB C.WSA WFC.PRL NFLX WFC.PRJ GOOG WFC.PRT C.WS.B ZION WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP C.PRU WFC.PRY WFC.PRX WFC.PRW WFC.PRV C.PRS WFC VFC WFC.WS C C.PRL C.PRJ C.PRK NYTAB C.PRG C.PRC JPM GOOGL C.PRPCL CGBBW PNC RTN

13
U.S. banks depositors shifting money, asking for higher rates

2018-07-16 reuters
NEW YORK, July 16 (Reuters) - Slowly but surely, depositors are starting to shift money from basic U.S. bank accounts to products that pay more than a sliver of a percent in interest.
WFCNP C.WSA WFC.PRL WFC.PRJ WFC.PRT C.WS.B WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP C.PRU WFC.PRY WFC.PRX WFC.PRW WFC.PRV C.PRS WFC WFC.WS C C.PRL PNC.PRP C.PRJ PNC.PRQ C.PRK PNCFO C.PRG C.PRC PNC.WS C.PRPCL CGBBW PNC PNUCL

12
Financials Begins Q2 Earnings On An Upbeat Note: 5 Fund Picks

2018-07-16 zacks
The financial sector has come up with encouraging earnings results amid rising rates. Big banks like JPMorgan Chase & Co. (JPM - Free Report) , Citigroup (C - Free Report) and The PNC Financial Services Group (PNC - Free Report) have all posted better-than-expected earnings results.
PRISX PNC.WS C GTT PNC.PRP PNC PNC.PRQ PNUCL PNCFO

64
JPMorgan Chase Beats on Earnings, But Will It Matter?

2018-07-14 investorplace
Once again, JPMorgan Chase (NYSE:JPM) has handily beat earnings estimates. JPM earnings for the second quarter came in nicely ahead of consensus. Revenue more than $1 billion higher than expected and EPS was 7 cents ahead of the Street.
WFC WFCNP WFC.WS C WFC.PRL WFC.PRJ BAC WFC.PRT WFC.PRR WFC.PRQ WFC.PRP JPM WFC.PRO WFC.PRN PNC WFC.PRY WFC.PRX WFC.PRW WFC.PRV

4
The PNC Financial Services Group, Inc. (PNC) CEO William Demchak on Q2 2018 Results - Earnings Call Transcript

2018-07-13 seekingalpha
The PNC Financial Services Group, Inc. (NYSE:PNC) Q2 2018 Earnings Conference Call July 13, 2018 9:30 AM ET
DB PNC.PRP PNC.PRQ MS.PRE MS.PRF PNCFO MS.PRG MS.PRA EVR PNC.WS MS.PRI MS.PRK PNC PNUCL MS

4
PNC Financial Services Group, Inc. 2018 Q2 - Results - Earnings Call Slides

2018-07-13 seekingalpha
The following slide deck was published by PNC Financial Services Group, Inc. in conjunction with their 2018 Q2 earnings call.
PNC.WS PNC.PRP PNC PNC.PRQ PNUCL PNCFO

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to PNC / PNC Financial Services Group, Inc. (The) on message board site Silicon Investor.

Spectranetics (SPNC): Any info? PNC BANK
PINNACLE MICRO (PNCL) - A QUALITY PICK FOR u002798 PNCL -- Buy/Sell/Hold in the New Year
CUSIP: 693475105